We are live on ! Find out more
KRRO icon

Korro Bio

83 hedge funds and large institutions have $60.6M invested in Korro Bio in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

9% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 22

10% less funds holding

Funds holding: 9283 (-9)

23.68% less ownership

Funds ownership: 103.97%80.3% (-24%)

27% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 30

87% less capital invested

Capital invested by funds: $466M → $60.6M (-$405M)

98% less call options, than puts

Call options by funds: $163K | Put options by funds: $7.93M

Holders
83
Holders Change
-9
Holders Change %
-9.78%
% of All Funds
1.01%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
22
Increased
24
Reduced
22
Closed
30
Calls
$163K
Puts
$7.93M
Net Calls
-$7.77M
Net Calls Change
-$7.77M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$303K -$12.3M -525,824 -93%
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$270K +$790K +33,790 New
ACM
28
AIHC Capital Management
$242K +$707K +30,265 New
Simplex Trading
29
Simplex Trading
Illinois
$226K +$660K +28,247 New
QCM
30
Quantinno Capital Management
New York
$221K +$502K +21,454 +349%
AG
31
Algert Global
California
$217K +$467K +19,957 +281%
QC
32
Quadrature Capital
United Kingdom
$217K +$633K +27,064 New
EGM
33
Engineers Gate Manager
New York
$215K +$628K +26,885 New
Raymond James Financial
34
Raymond James Financial
Florida
$184K -$2.94M -125,940 -85%
UBS Group
35
UBS Group
Switzerland
$160K -$774K -33,108 -62%
Marshall Wace
36
Marshall Wace
United Kingdom
$158K +$462K +19,772 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$151K -$10.7K -458 -2%
Charles Schwab
38
Charles Schwab
California
$131K -$158K -6,772 -29%
Deutsche Bank
39
Deutsche Bank
Germany
$102K +$211K +9,027 +242%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$90K -$4.02K -172 -2%
American Century Companies
41
American Century Companies
Missouri
$84.8K +$42.8K +1,833 +21%
JG
42
Jain Global
New York
$84.7K +$247K +10,574 New
GC
43
Guggenheim Capital
Illinois
$83.6K +$244K +10,439 New
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$82.1K +$21.2K +907 +10%
A
45
AlphaQuest
New York
$61.7K +$122K +5,235 +212%
Wells Fargo
46
Wells Fargo
California
$60.3K +$55K +2,352 +45%
Bank of America
47
Bank of America
North Carolina
$47.2K +$27.9K +1,192 +25%
Group One Trading
48
Group One Trading
Illinois
$32K +$93.5K +4,000 New
Mirae Asset Global ETFs Holdings
49
Mirae Asset Global ETFs Holdings
Hong Kong
$25.2K +$187 +8 +0.3%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$24K

KRRO Hedge Fund Activity: Q4 2025 in Review

83 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2025, worth a combined $60.6M — down 87% from $466M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of KRRO and 22 opened new positions — a net loss of 8 holders — while 22 trimmed existing stakes and 24 added.

The largest buyer was Lynx1 Capital Management, opening a new position worth an estimated $15.8M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $32.2M sold.

  • 83 institutional investors held Korro Bio (KRRO) as of Q4 2025, down from 92 in Q3 2025.
  • Funds reported $60.6M of Korro Bio stock for Q4 2025, down 87% quarter-over-quarter.
  • 22 funds opened new Korro Bio positions in Q4 2025 and 30 closed out, a net change of -8 holders.
  • The largest Korro Bio buyer in Q4 2025 was Lynx1 Capital Management, an estimated $15.8M added.
  • The largest Korro Bio seller in Q4 2025 was Driehaus Capital Management, an estimated $32.2M sold.

Based on aggregated 13F filings for Q4 2025.